Mucoactive agents in bronchiectasis: a systematic review and meta-analysis. (PubMed, Eur Respir Rev) - Jun 25, 2026 - "Pooled evidence did not show a reduction in exacerbations and FEV1 % pred improvements were small. Evidence certainty was low/very low, meaning overall clinical benefit remains uncertain, highlighting the need for targeted trials of specific agents and subgroups."
Clinical • Journal • Retrospective data • Review • Bronchiectasis • Cystic Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Inflammation • Pediatrics • Pulmonary Disease • Respiratory Diseases
|
|
Anthony De Soyza; Benjamin McCullough; Brenda O'Neill; Bronwen Connolly; Daniel F McAuley; Dermot Linden; J Stuart Elborn; James D Chalmers; John Busby; Judy M Bradley; Mike Clarke; Rebecca H McLeese
|